Medical Care
Global Mood Disorder Treatment Market Research Report 2025
- Jun 28, 25
- ID: 346071
- Pages: 75
- Figures: 80
- Views: 47
The global market for Mood Disorder Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Mood disorder treatment refers to the interventions and strategies used to manage and alleviate the symptoms of mood disorders, which are mental health conditions characterized by disturbances in mood, such as depression or bipolar disorder. The goal of treatment is to reduce symptoms, improve functioning, and enhance the overall quality of life for individuals affected by mood disorders.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mood Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mood Disorder Treatment.
The Mood Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mood Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mood Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MECTA Corporation
Ectron Limited
Somatics, LLC.
Alkermes
Eli Lilly and Company
Janssen Global Services, LLC (Johnson & Johnson)
Allergan (AbbVie Inc.)
Pfizer Inc.
Mylan N.V.
Novartis AG
Segment by Type
Medications
Psychotherapy
Brain Stimulation Therapies
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mood Disorder Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Mood disorder treatment refers to the interventions and strategies used to manage and alleviate the symptoms of mood disorders, which are mental health conditions characterized by disturbances in mood, such as depression or bipolar disorder. The goal of treatment is to reduce symptoms, improve functioning, and enhance the overall quality of life for individuals affected by mood disorders.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mood Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mood Disorder Treatment.
The Mood Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mood Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mood Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MECTA Corporation
Ectron Limited
Somatics, LLC.
Alkermes
Eli Lilly and Company
Janssen Global Services, LLC (Johnson & Johnson)
Allergan (AbbVie Inc.)
Pfizer Inc.
Mylan N.V.
Novartis AG
Segment by Type
Medications
Psychotherapy
Brain Stimulation Therapies
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mood Disorder Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mood Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medications
1.2.3 Psychotherapy
1.2.4 Brain Stimulation Therapies
1.3 Market by Application
1.3.1 Global Mood Disorder Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mood Disorder Treatment Market Perspective (2020-2031)
2.2 Global Mood Disorder Treatment Growth Trends by Region
2.2.1 Global Mood Disorder Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mood Disorder Treatment Historic Market Size by Region (2020-2025)
2.2.3 Mood Disorder Treatment Forecasted Market Size by Region (2026-2031)
2.3 Mood Disorder Treatment Market Dynamics
2.3.1 Mood Disorder Treatment Industry Trends
2.3.2 Mood Disorder Treatment Market Drivers
2.3.3 Mood Disorder Treatment Market Challenges
2.3.4 Mood Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mood Disorder Treatment Players by Revenue
3.1.1 Global Top Mood Disorder Treatment Players by Revenue (2020-2025)
3.1.2 Global Mood Disorder Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Mood Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mood Disorder Treatment Revenue
3.4 Global Mood Disorder Treatment Market Concentration Ratio
3.4.1 Global Mood Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mood Disorder Treatment Revenue in 2024
3.5 Global Key Players of Mood Disorder Treatment Head office and Area Served
3.6 Global Key Players of Mood Disorder Treatment, Product and Application
3.7 Global Key Players of Mood Disorder Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mood Disorder Treatment Breakdown Data by Type
4.1 Global Mood Disorder Treatment Historic Market Size by Type (2020-2025)
4.2 Global Mood Disorder Treatment Forecasted Market Size by Type (2026-2031)
5 Mood Disorder Treatment Breakdown Data by Application
5.1 Global Mood Disorder Treatment Historic Market Size by Application (2020-2025)
5.2 Global Mood Disorder Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mood Disorder Treatment Market Size (2020-2031)
6.2 North America Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mood Disorder Treatment Market Size by Country (2020-2025)
6.4 North America Mood Disorder Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mood Disorder Treatment Market Size (2020-2031)
7.2 Europe Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mood Disorder Treatment Market Size by Country (2020-2025)
7.4 Europe Mood Disorder Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mood Disorder Treatment Market Size (2020-2031)
8.2 Asia-Pacific Mood Disorder Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mood Disorder Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Mood Disorder Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mood Disorder Treatment Market Size (2020-2031)
9.2 Latin America Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mood Disorder Treatment Market Size by Country (2020-2025)
9.4 Latin America Mood Disorder Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mood Disorder Treatment Market Size (2020-2031)
10.2 Middle East & Africa Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mood Disorder Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Mood Disorder Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MECTA Corporation
11.1.1 MECTA Corporation Company Details
11.1.2 MECTA Corporation Business Overview
11.1.3 MECTA Corporation Mood Disorder Treatment Introduction
11.1.4 MECTA Corporation Revenue in Mood Disorder Treatment Business (2020-2025)
11.1.5 MECTA Corporation Recent Development
11.2 Ectron Limited
11.2.1 Ectron Limited Company Details
11.2.2 Ectron Limited Business Overview
11.2.3 Ectron Limited Mood Disorder Treatment Introduction
11.2.4 Ectron Limited Revenue in Mood Disorder Treatment Business (2020-2025)
11.2.5 Ectron Limited Recent Development
11.3 Somatics, LLC.
11.3.1 Somatics, LLC. Company Details
11.3.2 Somatics, LLC. Business Overview
11.3.3 Somatics, LLC. Mood Disorder Treatment Introduction
11.3.4 Somatics, LLC. Revenue in Mood Disorder Treatment Business (2020-2025)
11.3.5 Somatics, LLC. Recent Development
11.4 Alkermes
11.4.1 Alkermes Company Details
11.4.2 Alkermes Business Overview
11.4.3 Alkermes Mood Disorder Treatment Introduction
11.4.4 Alkermes Revenue in Mood Disorder Treatment Business (2020-2025)
11.4.5 Alkermes Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Mood Disorder Treatment Introduction
11.5.4 Eli Lilly and Company Revenue in Mood Disorder Treatment Business (2020-2025)
11.5.5 Eli Lilly and Company Recent Development
11.6 Janssen Global Services, LLC (Johnson & Johnson)
11.6.1 Janssen Global Services, LLC (Johnson & Johnson) Company Details
11.6.2 Janssen Global Services, LLC (Johnson & Johnson) Business Overview
11.6.3 Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Introduction
11.6.4 Janssen Global Services, LLC (Johnson & Johnson) Revenue in Mood Disorder Treatment Business (2020-2025)
11.6.5 Janssen Global Services, LLC (Johnson & Johnson) Recent Development
11.7 Allergan (AbbVie Inc.)
11.7.1 Allergan (AbbVie Inc.) Company Details
11.7.2 Allergan (AbbVie Inc.) Business Overview
11.7.3 Allergan (AbbVie Inc.) Mood Disorder Treatment Introduction
11.7.4 Allergan (AbbVie Inc.) Revenue in Mood Disorder Treatment Business (2020-2025)
11.7.5 Allergan (AbbVie Inc.) Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Mood Disorder Treatment Introduction
11.8.4 Pfizer Inc. Revenue in Mood Disorder Treatment Business (2020-2025)
11.8.5 Pfizer Inc. Recent Development
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Details
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Mood Disorder Treatment Introduction
11.9.4 Mylan N.V. Revenue in Mood Disorder Treatment Business (2020-2025)
11.9.5 Mylan N.V. Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Mood Disorder Treatment Introduction
11.10.4 Novartis AG Revenue in Mood Disorder Treatment Business (2020-2025)
11.10.5 Novartis AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mood Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medications
1.2.3 Psychotherapy
1.2.4 Brain Stimulation Therapies
1.3 Market by Application
1.3.1 Global Mood Disorder Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mood Disorder Treatment Market Perspective (2020-2031)
2.2 Global Mood Disorder Treatment Growth Trends by Region
2.2.1 Global Mood Disorder Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mood Disorder Treatment Historic Market Size by Region (2020-2025)
2.2.3 Mood Disorder Treatment Forecasted Market Size by Region (2026-2031)
2.3 Mood Disorder Treatment Market Dynamics
2.3.1 Mood Disorder Treatment Industry Trends
2.3.2 Mood Disorder Treatment Market Drivers
2.3.3 Mood Disorder Treatment Market Challenges
2.3.4 Mood Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mood Disorder Treatment Players by Revenue
3.1.1 Global Top Mood Disorder Treatment Players by Revenue (2020-2025)
3.1.2 Global Mood Disorder Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Mood Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mood Disorder Treatment Revenue
3.4 Global Mood Disorder Treatment Market Concentration Ratio
3.4.1 Global Mood Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mood Disorder Treatment Revenue in 2024
3.5 Global Key Players of Mood Disorder Treatment Head office and Area Served
3.6 Global Key Players of Mood Disorder Treatment, Product and Application
3.7 Global Key Players of Mood Disorder Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mood Disorder Treatment Breakdown Data by Type
4.1 Global Mood Disorder Treatment Historic Market Size by Type (2020-2025)
4.2 Global Mood Disorder Treatment Forecasted Market Size by Type (2026-2031)
5 Mood Disorder Treatment Breakdown Data by Application
5.1 Global Mood Disorder Treatment Historic Market Size by Application (2020-2025)
5.2 Global Mood Disorder Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mood Disorder Treatment Market Size (2020-2031)
6.2 North America Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mood Disorder Treatment Market Size by Country (2020-2025)
6.4 North America Mood Disorder Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mood Disorder Treatment Market Size (2020-2031)
7.2 Europe Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mood Disorder Treatment Market Size by Country (2020-2025)
7.4 Europe Mood Disorder Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mood Disorder Treatment Market Size (2020-2031)
8.2 Asia-Pacific Mood Disorder Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mood Disorder Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Mood Disorder Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mood Disorder Treatment Market Size (2020-2031)
9.2 Latin America Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mood Disorder Treatment Market Size by Country (2020-2025)
9.4 Latin America Mood Disorder Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mood Disorder Treatment Market Size (2020-2031)
10.2 Middle East & Africa Mood Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mood Disorder Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Mood Disorder Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MECTA Corporation
11.1.1 MECTA Corporation Company Details
11.1.2 MECTA Corporation Business Overview
11.1.3 MECTA Corporation Mood Disorder Treatment Introduction
11.1.4 MECTA Corporation Revenue in Mood Disorder Treatment Business (2020-2025)
11.1.5 MECTA Corporation Recent Development
11.2 Ectron Limited
11.2.1 Ectron Limited Company Details
11.2.2 Ectron Limited Business Overview
11.2.3 Ectron Limited Mood Disorder Treatment Introduction
11.2.4 Ectron Limited Revenue in Mood Disorder Treatment Business (2020-2025)
11.2.5 Ectron Limited Recent Development
11.3 Somatics, LLC.
11.3.1 Somatics, LLC. Company Details
11.3.2 Somatics, LLC. Business Overview
11.3.3 Somatics, LLC. Mood Disorder Treatment Introduction
11.3.4 Somatics, LLC. Revenue in Mood Disorder Treatment Business (2020-2025)
11.3.5 Somatics, LLC. Recent Development
11.4 Alkermes
11.4.1 Alkermes Company Details
11.4.2 Alkermes Business Overview
11.4.3 Alkermes Mood Disorder Treatment Introduction
11.4.4 Alkermes Revenue in Mood Disorder Treatment Business (2020-2025)
11.4.5 Alkermes Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Mood Disorder Treatment Introduction
11.5.4 Eli Lilly and Company Revenue in Mood Disorder Treatment Business (2020-2025)
11.5.5 Eli Lilly and Company Recent Development
11.6 Janssen Global Services, LLC (Johnson & Johnson)
11.6.1 Janssen Global Services, LLC (Johnson & Johnson) Company Details
11.6.2 Janssen Global Services, LLC (Johnson & Johnson) Business Overview
11.6.3 Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Introduction
11.6.4 Janssen Global Services, LLC (Johnson & Johnson) Revenue in Mood Disorder Treatment Business (2020-2025)
11.6.5 Janssen Global Services, LLC (Johnson & Johnson) Recent Development
11.7 Allergan (AbbVie Inc.)
11.7.1 Allergan (AbbVie Inc.) Company Details
11.7.2 Allergan (AbbVie Inc.) Business Overview
11.7.3 Allergan (AbbVie Inc.) Mood Disorder Treatment Introduction
11.7.4 Allergan (AbbVie Inc.) Revenue in Mood Disorder Treatment Business (2020-2025)
11.7.5 Allergan (AbbVie Inc.) Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Mood Disorder Treatment Introduction
11.8.4 Pfizer Inc. Revenue in Mood Disorder Treatment Business (2020-2025)
11.8.5 Pfizer Inc. Recent Development
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Details
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Mood Disorder Treatment Introduction
11.9.4 Mylan N.V. Revenue in Mood Disorder Treatment Business (2020-2025)
11.9.5 Mylan N.V. Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Mood Disorder Treatment Introduction
11.10.4 Novartis AG Revenue in Mood Disorder Treatment Business (2020-2025)
11.10.5 Novartis AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mood Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Medications
Table 3. Key Players of Psychotherapy
Table 4. Key Players of Brain Stimulation Therapies
Table 5. Global Mood Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Mood Disorder Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Mood Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Mood Disorder Treatment Market Share by Region (2020-2025)
Table 9. Global Mood Disorder Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Mood Disorder Treatment Market Share by Region (2026-2031)
Table 11. Mood Disorder Treatment Market Trends
Table 12. Mood Disorder Treatment Market Drivers
Table 13. Mood Disorder Treatment Market Challenges
Table 14. Mood Disorder Treatment Market Restraints
Table 15. Global Mood Disorder Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Mood Disorder Treatment Market Share by Players (2020-2025)
Table 17. Global Top Mood Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mood Disorder Treatment as of 2024)
Table 18. Ranking of Global Top Mood Disorder Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Mood Disorder Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Mood Disorder Treatment, Headquarters and Area Served
Table 21. Global Key Players of Mood Disorder Treatment, Product and Application
Table 22. Global Key Players of Mood Disorder Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Mood Disorder Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Mood Disorder Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Mood Disorder Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Mood Disorder Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Mood Disorder Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Mood Disorder Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Mood Disorder Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Mood Disorder Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Mood Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Mood Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Mood Disorder Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. MECTA Corporation Company Details
Table 48. MECTA Corporation Business Overview
Table 49. MECTA Corporation Mood Disorder Treatment Product
Table 50. MECTA Corporation Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 51. MECTA Corporation Recent Development
Table 52. Ectron Limited Company Details
Table 53. Ectron Limited Business Overview
Table 54. Ectron Limited Mood Disorder Treatment Product
Table 55. Ectron Limited Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 56. Ectron Limited Recent Development
Table 57. Somatics, LLC. Company Details
Table 58. Somatics, LLC. Business Overview
Table 59. Somatics, LLC. Mood Disorder Treatment Product
Table 60. Somatics, LLC. Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 61. Somatics, LLC. Recent Development
Table 62. Alkermes Company Details
Table 63. Alkermes Business Overview
Table 64. Alkermes Mood Disorder Treatment Product
Table 65. Alkermes Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 66. Alkermes Recent Development
Table 67. Eli Lilly and Company Company Details
Table 68. Eli Lilly and Company Business Overview
Table 69. Eli Lilly and Company Mood Disorder Treatment Product
Table 70. Eli Lilly and Company Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 71. Eli Lilly and Company Recent Development
Table 72. Janssen Global Services, LLC (Johnson & Johnson) Company Details
Table 73. Janssen Global Services, LLC (Johnson & Johnson) Business Overview
Table 74. Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Product
Table 75. Janssen Global Services, LLC (Johnson & Johnson) Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 76. Janssen Global Services, LLC (Johnson & Johnson) Recent Development
Table 77. Allergan (AbbVie Inc.) Company Details
Table 78. Allergan (AbbVie Inc.) Business Overview
Table 79. Allergan (AbbVie Inc.) Mood Disorder Treatment Product
Table 80. Allergan (AbbVie Inc.) Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 81. Allergan (AbbVie Inc.) Recent Development
Table 82. Pfizer Inc. Company Details
Table 83. Pfizer Inc. Business Overview
Table 84. Pfizer Inc. Mood Disorder Treatment Product
Table 85. Pfizer Inc. Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 86. Pfizer Inc. Recent Development
Table 87. Mylan N.V. Company Details
Table 88. Mylan N.V. Business Overview
Table 89. Mylan N.V. Mood Disorder Treatment Product
Table 90. Mylan N.V. Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 91. Mylan N.V. Recent Development
Table 92. Novartis AG Company Details
Table 93. Novartis AG Business Overview
Table 94. Novartis AG Mood Disorder Treatment Product
Table 95. Novartis AG Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 96. Novartis AG Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Mood Disorder Treatment Picture
Figure 2. Global Mood Disorder Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mood Disorder Treatment Market Share by Type: 2024 VS 2031
Figure 4. Medications Features
Figure 5. Psychotherapy Features
Figure 6. Brain Stimulation Therapies Features
Figure 7. Global Mood Disorder Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Mood Disorder Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Specialty Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Mood Disorder Treatment Report Years Considered
Figure 13. Global Mood Disorder Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Mood Disorder Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Mood Disorder Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Mood Disorder Treatment Market Share by Players in 2024
Figure 17. Global Top Mood Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mood Disorder Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Mood Disorder Treatment Revenue in 2024
Figure 19. North America Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Mood Disorder Treatment Market Share by Country (2020-2031)
Figure 21. United States Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Mood Disorder Treatment Market Share by Country (2020-2031)
Figure 25. Germany Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Mood Disorder Treatment Market Share by Region (2020-2031)
Figure 33. China Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Mood Disorder Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Mood Disorder Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. MECTA Corporation Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 49. Ectron Limited Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 50. Somatics, LLC. Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 51. Alkermes Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 53. Janssen Global Services, LLC (Johnson & Johnson) Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 54. Allergan (AbbVie Inc.) Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 55. Pfizer Inc. Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 56. Mylan N.V. Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 57. Novartis AG Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Mood Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Medications
Table 3. Key Players of Psychotherapy
Table 4. Key Players of Brain Stimulation Therapies
Table 5. Global Mood Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Mood Disorder Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Mood Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Mood Disorder Treatment Market Share by Region (2020-2025)
Table 9. Global Mood Disorder Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Mood Disorder Treatment Market Share by Region (2026-2031)
Table 11. Mood Disorder Treatment Market Trends
Table 12. Mood Disorder Treatment Market Drivers
Table 13. Mood Disorder Treatment Market Challenges
Table 14. Mood Disorder Treatment Market Restraints
Table 15. Global Mood Disorder Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Mood Disorder Treatment Market Share by Players (2020-2025)
Table 17. Global Top Mood Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mood Disorder Treatment as of 2024)
Table 18. Ranking of Global Top Mood Disorder Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Mood Disorder Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Mood Disorder Treatment, Headquarters and Area Served
Table 21. Global Key Players of Mood Disorder Treatment, Product and Application
Table 22. Global Key Players of Mood Disorder Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Mood Disorder Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Mood Disorder Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Mood Disorder Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Mood Disorder Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Mood Disorder Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Mood Disorder Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Mood Disorder Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Mood Disorder Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Mood Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Mood Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Mood Disorder Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Mood Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Mood Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Mood Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. MECTA Corporation Company Details
Table 48. MECTA Corporation Business Overview
Table 49. MECTA Corporation Mood Disorder Treatment Product
Table 50. MECTA Corporation Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 51. MECTA Corporation Recent Development
Table 52. Ectron Limited Company Details
Table 53. Ectron Limited Business Overview
Table 54. Ectron Limited Mood Disorder Treatment Product
Table 55. Ectron Limited Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 56. Ectron Limited Recent Development
Table 57. Somatics, LLC. Company Details
Table 58. Somatics, LLC. Business Overview
Table 59. Somatics, LLC. Mood Disorder Treatment Product
Table 60. Somatics, LLC. Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 61. Somatics, LLC. Recent Development
Table 62. Alkermes Company Details
Table 63. Alkermes Business Overview
Table 64. Alkermes Mood Disorder Treatment Product
Table 65. Alkermes Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 66. Alkermes Recent Development
Table 67. Eli Lilly and Company Company Details
Table 68. Eli Lilly and Company Business Overview
Table 69. Eli Lilly and Company Mood Disorder Treatment Product
Table 70. Eli Lilly and Company Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 71. Eli Lilly and Company Recent Development
Table 72. Janssen Global Services, LLC (Johnson & Johnson) Company Details
Table 73. Janssen Global Services, LLC (Johnson & Johnson) Business Overview
Table 74. Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Product
Table 75. Janssen Global Services, LLC (Johnson & Johnson) Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 76. Janssen Global Services, LLC (Johnson & Johnson) Recent Development
Table 77. Allergan (AbbVie Inc.) Company Details
Table 78. Allergan (AbbVie Inc.) Business Overview
Table 79. Allergan (AbbVie Inc.) Mood Disorder Treatment Product
Table 80. Allergan (AbbVie Inc.) Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 81. Allergan (AbbVie Inc.) Recent Development
Table 82. Pfizer Inc. Company Details
Table 83. Pfizer Inc. Business Overview
Table 84. Pfizer Inc. Mood Disorder Treatment Product
Table 85. Pfizer Inc. Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 86. Pfizer Inc. Recent Development
Table 87. Mylan N.V. Company Details
Table 88. Mylan N.V. Business Overview
Table 89. Mylan N.V. Mood Disorder Treatment Product
Table 90. Mylan N.V. Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 91. Mylan N.V. Recent Development
Table 92. Novartis AG Company Details
Table 93. Novartis AG Business Overview
Table 94. Novartis AG Mood Disorder Treatment Product
Table 95. Novartis AG Revenue in Mood Disorder Treatment Business (2020-2025) & (US$ Million)
Table 96. Novartis AG Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Mood Disorder Treatment Picture
Figure 2. Global Mood Disorder Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mood Disorder Treatment Market Share by Type: 2024 VS 2031
Figure 4. Medications Features
Figure 5. Psychotherapy Features
Figure 6. Brain Stimulation Therapies Features
Figure 7. Global Mood Disorder Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Mood Disorder Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Specialty Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Mood Disorder Treatment Report Years Considered
Figure 13. Global Mood Disorder Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Mood Disorder Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Mood Disorder Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Mood Disorder Treatment Market Share by Players in 2024
Figure 17. Global Top Mood Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mood Disorder Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Mood Disorder Treatment Revenue in 2024
Figure 19. North America Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Mood Disorder Treatment Market Share by Country (2020-2031)
Figure 21. United States Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Mood Disorder Treatment Market Share by Country (2020-2031)
Figure 25. Germany Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Mood Disorder Treatment Market Share by Region (2020-2031)
Figure 33. China Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Mood Disorder Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Mood Disorder Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Mood Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. MECTA Corporation Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 49. Ectron Limited Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 50. Somatics, LLC. Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 51. Alkermes Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 53. Janssen Global Services, LLC (Johnson & Johnson) Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 54. Allergan (AbbVie Inc.) Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 55. Pfizer Inc. Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 56. Mylan N.V. Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 57. Novartis AG Revenue Growth Rate in Mood Disorder Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232